| 
Actualizaciones en la gestión de farmacias
Humana strives to make the prescription
process as simple as possible for providers and members. Some prescriptions,
however, require more attention than others.
The Humana Clinical
Pharmacy Review (HCPR) team oversees step therapy and handles requests
related to prior authorization and overriding dispensing limits.
The team is centrally located in Louisville, Ky., and operates
Monday-Friday, 8 a.m. to 9 p.m. EST.
Autorizaciones previas Algunos medicamentos deben atravesar un proceso de aprobación basado en criterios, previo a una decisión de cobertura. If you need to obtain prior authorization
for a prescription, you can use one of the following methods:
1) Submit your
request online with the new Web tool. (See the box on this page
for more information.)
2) Call HCPR at 1-800-555-CLIN (2546), Monday-Friday,
8 a.m. to 9 p.m. EST. When calling in a request, be prepared
with the following information:
- Información demográfica del paciente
- El medicamento solicitado
- El diagnóstico del paciente
- Any drug allergies or medical conditions
- Otros tratamientos o procedimientos probados
- Duración deseada del tratamiento
Most requests for authorization require
appropriate lab information before they can be processed.
3) Fax the
form to HCPR at (877) 486-2621. Fax forms can be downloaded online
through the following process:
- Go to the "Provider" area
of www.humana.com
- Under "Quick Links," choose "Prescription
Tools"
- Scroll down to the "Prior Authorization" link
You
can also view a list of drugs that require prior authorization
by clicking on "Humana's Drug List" on the
same page as the "Prior Authorization" link.
Límites máximos de venta
Maximum dispensing limits are based on product information approved
by the Federal Drug Administration (FDA) and recommendations
from the drug's manufacturer. These limits are reviewed and approved
by Humana's Pharmacy and Therapeutics Committee, which is composed
of both pharmacists and physicians.
If a patient's medical condition
warrants additional quantities, call HCPR at 1-800-555-CLIN (2546),
Monday-Friday, 8 a.m.-9 p.m. EST. You should be prepared with the
same information as for a prior authorization request (see list
at left). For a list of drugs with a dispensing limit, take the
following steps:
- Go to the "Provider" area of www.humana.com
- Under "Quick
Links," choose "Prescription Tools"
- Choose "Humana's
Drug List"
- Click on the link under "Quantity Limit" under "Updates"
Terapia escalonada
The Medicare Prescription Drug Plan is subject to step therapy
protocols. Step therapy protocols require patients to utilize
medications commonly considered first-line before using medications considered
second-line or third-line. Estos protocolos se utilizan para promover pautas de tratamiento nacionales establecidas. Además, los protocolos de terapia escalonada contribuyen a la promoción de terapias con medicamentos seguros y accesibles.
Some drugs are
restricted to a particular gender and/or age group for coverage.
This is based on how the drug is to be used and the subpopulation
the drug is intended to treat.
If you have questions about a step therapy regimen, call
HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m. - 9 p.m. EST.
Excepción y rechazo de solicitudes
For an exception to a Medicare Part D drug management tool, providers
should call HCPR at 1-800-555-CLIN (2546), Monday-Friday, 8 a.m.-9
p.m. EST.
For information about Exception and Appeals take the following
steps:
- Go to the "Provider" area of www.humana.com
- Under "Quick
Links," choose "Prescription Tools"
- Scroll
down to the "Exception and Appeals" link
Generally,
HCPR will give providers a decision within 72 hours of receiving
their supporting statement for authorization. Providers can request
an expedited review if the standard response time would cause serious
harm or endanger a member's health.
HCPR will make the decision within 24 hours if the patient's
medical condition requires it.
Volver arriba
Web-based authorizations
now available!
Providers now have
a faster way to request drug prior authorizations (PAs) –
via the Web. The Web PA tool aims to help providers save
time and eliminate confusion for physicians and their patients.
The advantages of this service include the following:
- Immediate
response from Humana on drug PA requests
- Aprobación al instante
- Ability to fill prescriptions that require a PA more
quickly
This market-leading innovation is available 24 hours
a day in Humana's secured Provider Resource Center.
To get to the tool, follow these instructions:
- Log in to
Humana's Provider Resource Center
- Click the "Drug
Prior Authorization Requests" link
under the "Referrals/Authorizations" section
- Follow the instructions and submit the request
Some drugs
available for Web PA as of April 2007 include the following:
- Byetta,
Januvia, Janumet
- Lamisil
- Norvasc and other blood pressure drugs
- Nexium, Prilosec,
Omeprazole, Protonix, Aciphex, Prevacid and Zegerid
- Celebrex,
Mobic and Meloxicam
|
| Volver arriba |
Humana wants physicians
to know that the following brand name drugs are now available
generically:
- Zocor
- Zoloft
- Pravachol
- Ditropan XL
- Mobic
- Norvasc
|
- Proscar
- Prilosec
- Flonase
- Allegra
- Claritin
|
|
| Volver arriba |
CMS definition
of a Part D Drug
A prescription
drug is a Part D drug only if it is prescribed for a medically
accepted indication as defined by Medicare statute. This definition
includes uses which are approved by the FDA or supported by
a citation included, or approved for inclusion, in one of the
following compendia:
- American Hospital Formulary Service Drug
Information
- United States Pharmacopeia-Drug Information
- DRUGDEX Information
System
Based on this statutory definition, indications that
are supported in peer-reviewed medical literature that
have not yet been approved by the FDA or reflected in one
of the compendia are not medically accepted. Therefore, the
use of a drug for such indications would not meet the definition
of a Part D drug and is not payable under the Medicare Part
D benefit. |
| Volver arriba |
|